Washington Trust’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6
| Closed | -$402 | – | 860 |
|
|
2024
Q3 | $402 | Hold |
6
| – | – | ﹤0.01% | 836 |
|
|
2024
Q2 | $680 | Buy |
+6
| New | +$680 | ﹤0.01% | 848 |
|
|
2023
Q4 | – | Sell |
-110
| Closed | -$10.3K | – | 863 |
|
|
2023
Q3 | $10.3K | Buy |
110
+3
| +3% | +$280 | ﹤0.01% | 622 |
|
|
2023
Q2 | $13.8K | Sell |
107
-3
| -3% | -$386 | ﹤0.01% | 612 |
|
|
2023
Q1 | $12.8K | Sell |
110
-4
| -4% | -$465 | ﹤0.01% | 628 |
|
|
2022
Q4 | $12.9K | Buy |
114
+1
| +0.9% | +$113 | ﹤0.01% | 619 |
|
|
2022
Q3 | $9K | Sell |
113
-7
| -6% | -$558 | ﹤0.01% | 656 |
|
|
2022
Q2 | $9K | Buy |
120
+8
| +7% | +$600 | ﹤0.01% | 656 |
|
|
2022
Q1 | $14K | Buy |
112
+48
| +75% | +$6K | ﹤0.01% | 636 |
|
|
2021
Q4 | $9K | Sell |
64
-28
| -30% | -$3.94K | ﹤0.01% | 683 |
|
|
2021
Q3 | $13K | Hold |
92
| – | – | ﹤0.01% | 749 |
|
|
2021
Q2 | $10K | Buy |
+92
| New | +$10K | ﹤0.01% | 779 |
|